141 related articles for article (PubMed ID: 15828168)
1. Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs.
Marks MI
Antimicrob Agents Chemother; 1974 Jul; 6(1):34-8. PubMed ID: 15828168
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside.
Babiuk LA; Meldrum B; Gupta VS; Rouse BT
Antimicrob Agents Chemother; 1975 Dec; 8(6):643-50. PubMed ID: 1239978
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains.
Fiala M; Chow A; Guze LB
Antimicrob Agents Chemother; 1972 Apr; 1(4):354-7. PubMed ID: 4364937
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
Field H; McMillan A; Darby G
J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.
Herrmann EC
Appl Microbiol; 1968 Aug; 16(8):1151-5. PubMed ID: 4300089
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
Gephart JF; Lerner AM
Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
[TBL] [Abstract][Full Text] [Related]
9. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
10. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
Prusoff WH; Mancini WR; Lin TS; Lee JJ; Siegel SA; Otto MJ
Antiviral Res; 1984 Dec; 4(6):303-15. PubMed ID: 6099709
[TBL] [Abstract][Full Text] [Related]
11. A rapid antiviral drug test by enzyme-linked immunoassay.
Landini MP; Baldassarri B
Diagn Immunol; 1983; 1(4):284-7. PubMed ID: 6094087
[TBL] [Abstract][Full Text] [Related]
12. Effect of anti-herpesvirus drugs on human and bovine lymphoid function in vitro.
Babiuk LA; Rouse BT
Infect Immun; 1975 Dec; 12(6):1281-9. PubMed ID: 173654
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
Smith KO; Kennell WL; Poirier RH; Lynd FT
Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
[TBL] [Abstract][Full Text] [Related]
14. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
Charles SJ; Gray JJ
Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro imunotoxicology of acyclovir and other antiviral agents.
Steele RW; Marmer DJ; Keeney RE
Infect Immun; 1980 Jun; 28(3):957-62. PubMed ID: 6249751
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
[TBL] [Abstract][Full Text] [Related]
17. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine.
Yoshida T; Suzutani T; Azuma M
Tohoku J Exp Med; 1988 Nov; 156(3):279-90. PubMed ID: 2855280
[TBL] [Abstract][Full Text] [Related]
18. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
Cermak-Mörth CM; Christian R; Unger FM
Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
[No Abstract] [Full Text] [Related]
19. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection.
Rabalais GP; Nusinoff-Lehrman S; Arvin AM; Levin MJ
Pediatr Infect Dis J; 1989 Apr; 8(4):221-3. PubMed ID: 2541398
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
Alenius S
Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
